CONCLUSION

The successful treatment of spina bifida requires a mul­tidisciplinary team approach. Education of the child and family regarding lifelong expectations are a criti­cal part of multidisciplinary management.

The Spina Bifida Association of America (SBAA) can be contacted at 4590 MacArthur Boulevard NW, Suite 250, Washington, D.C. 20007-4226, by phone on 202-944-3285, or on the Web at www.spinabifidaas- sociation.org.

The SBAA has a one-year college scholarship pro­gram, established in 1988, to assist persons with spina bifida in pursuing higher education.

REFERENCES

1. American Academy of Pediatrics policy statement, 1999.

2. Deak KL, Siegel DG, George TM, et al. Further evidence for a maternal genetic effect and a sex-influenced effect contribut­ing to risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol 2008;82(10):662-669.

3. Dias MS, McLone DG, Partington M. Normal and abnormal embryology of the spinal cord and spine. In Winn HR, ed: Youmans Neurological Surgery, 5th ed. Philadelphia: WB Saunders; 2003;4239-4288.

4. Dias MS, McLone DG. Normal and abnormal early develop­ment of the nervous system. In McLone DG, ed: Pediatric Neurosurgery: Surgery of the Developing Nervous System, 4th ed.. Philadelphia: WB Saunders, 2001;31-71.

5. Dias MS, Partington M. Embryology of myelomeningocele and anencephaly.

6. Northrup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr 2000;30(10):313-332.

7. Van Allen MI. Multisite neural tube closure in humans. Birth Defects Orig Artic Ser 1996;30(1):203-225.

8. Van Allen MI, Kalousek DK, Chernoff GF, et al.. Evidence for multi-site closure of the neural tube in humans. Am JMed Genet 1993;47(5):723-743.

9. McLone DG, Knepper PA. The cause of Chiari II malforma­tion: a unified theory. Pediatr Neurosci 1989;15(1):1-12.

10. Dias MS, Pang D. Split cord malformations. Neurosurg Clin N Am 1995;6(2):339-358.

11. Dias MS, Walker ML: The embryogenesis of complex dys- raphic malformations: a disorder of gastrulation? Pediatr Neurosurg 1992;18(5-6):229-253.

12. Schoenwolf GC. Microsurgical analyses of avian neurula- tion: separation of medial and lateral tissues. J Comp Neurol 1988 ;276(4):498-507.

13. Smith JL, Schoenwolf GC. Further evidence of extrin­sic forces in bending of the neural plate. J Comp Neurol 1991;307(2):225-236.

14. Smith JL, Schoenwolf GC, Quan J. Quantitative analyses of neuroepithelial cell shapes during bending of the mouse neural plate. J Comp Neurol 1994;342(1):144-151.

15. Chambers CD. Risks of hyperthermia associated with hot tub or spa use by pregnant women. Birth Defects Res A Clin Mol Teratol 2006;76(8):569-573.

16. Edwards MJ. Review: Hyperthermia and fever during pregnancy. Birth Defects Res A Clin Mol Teratol 2006; 76(7):507-516.

17. Lynberg MC, Khoury MJ, Lu X, et al.. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 1994;140(3):244-255.

18. Milunsky A, Ulcickas M, Rothman KJ, et al.. Maternal heat exposure and neural tube defects. JAMA 1992 19; 268(7):882-885.

19. Sandford MK, Kissling GE, Joubert PE. Neural tube defect etiology: new evidence concerning maternal hyperthermia, health and diet. Dev Med Child Neurol 1992;34(8):661-675.

20. Watts DH. Teratogenicity risk of antiretroviral therapy in pregnancy.

21. Sutow WW, Pryde AW. Incidence of spina bifida occulta in relation to age. Am J Dis Child 1956;91(3):211-217.

22. Zambito A, Dall'oca C, Polo A, et al. Spina bifida occulta. Foot deformities, enuresis and vertebral cleft: clinical pic­ture and neurophysiological assessment. Eur J Phys Rehabil Med 2008 Dec;44(4):437-440. 23. Aicardi J. Diseases of the nervous system in childhood. Clinics in Developmental Medicine, no. 115/118. New York: Cambridge University Press, 1992.

24. Menkes JS. Textbook of Child Neurology. Philadelphia: Lea and Febiger, 1990.

25. Shurtleff DB, ed. Myelodysplasias and Extrophies: Significance, Prevention and Treatment. New York: Grune and Stratton, 1986.

26. Mayfield JK. Comprehensive orthopedic management in myelomeningocele. In Rekate HL, ed: Comprehensive Management of Spina Bifida. Boston: CRC Press, 1991.

27. Rekate HL, ed. Comprehensive Management of Spina Bifida. Boston: CRC Press, 1991.

28. Brocklehurst G, ed. Spina Bifida for the Clinician. Philadelphia: Lippincott, 1976.

29. Mazur, JM, Menalaus MD. Neurologic status of spina bifida patients and the orthopedic surgeon. Clin Orthop Relat Res 1991;264:54-64.

30. Cochrane DD, Rassekh SR, Thiessen PN. Functional dete­rioration following placode untethering in myelomeningo­cele. Pediatr Neurosurg;28(2):57-62.

31. Sarwark JF, Weber DT, Gabrieli AP, et al.. Tethered cord syndrome in low motor level children with myelomeningo­cele. Pediatr Neurosurg 1996;25(6):295-301.

32. McLone DG, Herman JM, Gabrieli AP, et al.. Tethered cord as a cause of scoliosis in children with a myelomeningo­cele. Pediatr Neurosurg 1990-1991;16(1):8-13.

33. McLone DG, La Marca F. The tethered spinal cord: diagno­sis, significance, and management. Semin Pediatr Neurol 1997;4(3):192-208.

34. Gilbert JN, Jones KI, Rorke LB, et al.. Central nervous sys­tem anomalies associated with myelomeningocele, hydro­cephalus and Arnold-Chiari malformation: Reappraisal of theories regarding the pathogenesis of posterior neural tube closure defects.

35. Swaiman KF, Wright FS, eds. The Practice of Pediatric Neurology, 2nd ed. St. Louis: Mosby, 1982.

36. AzimullahPC,SmitLM,Rietveld-KnolE,etal..Malformations of the spinal cord in 53 patients with spina bifida stud­ied by magnetic resonance imaging. Childs Nerv Syst 1991; 7(2):63-66.

37. Wilson DA, Prince JR. MR imaging determination of the location of conus medullaris throughout childhood. Am J Roentgenol 1989;152:1029.

38. Bowman RM, McLone DG, Grant JA, et al.. Spina bifida outcome: A 25 year prospective. Pediatr Neurosurg 2001; 34(3):114-120.

39. Dias MS, McLone DG: Hydrocephalus in the child with dys- raphism. Neurosurg Clin N Am 1993 Oct;4(4):715-726.

40. Schoenmakers MA, Gooskens RH, Gulmans VA, et al. Long­term outcome of neurosurgical untethering on neuroseg- mental motor and ambulation levels. Dev Med Child Neurol 2003;45(8):551-555.

41. Rinaldi F, Cioffi FA, Columbano L, et al.. Tethered cord syn­drome. J Neurosurg Sci 2005;49(4):131-135.

42. Harwood-Nash DC, McHugh K. Diastomatomyelia in 172 children: The impact of modern neuroradiology. Pediatr Neurosurg 1990-1991;16(4-5):247-251.

43. Mahapatra AK, Gupta DK. Split Cord malformations: A clin­ical study of 254 patients and a proposal for a new clini­cal imaging classification. J Neurosurg 2005;103(6 Suppl): 531-536.

44. Guthkelch AN: Distomatomyelia with a median septum. Brain 1974;97(4):729-742.

45. James CC, Lassman LP: Diastematomyelia: a critical sur­vey of 24 cases submitted to laminectomy. Arch Dis Child 1964;39:125-130.

46. RussellNA,BenoitBG,JoaquinAJ.Diastematomyeliainadults: A review. Pediatr Neurosurg 1990-91;16(4-5):252-257.

47. Gardner JW. Hydrodynamic mechanism of syringomyelia: its relationship to myelocele. J Neurol Neurosurg Psychiatry 1965;28:247-259.

48. Caldarelli M, Di Rocco C, La Marca F. Treatment of hydro- myelia in spina bifida. Surg Neurol 1998;50(5):411-420.

49. Tashiro K, Fukazawa T, Moriwaka F, et al..

50. Samuelson L, Bergstrom K, et al.. MR imaging of syrin- gohydromyelia and Chiari malformation in myelomeningo­cele patients with scoliosis. Am J Neurol 1987;8:539.

51. Park TS, Hoffman JH, et al.. Experience with surgical decompression of the Arnold-Chiari malformation in young adults with myelomeningocele. Neurosurgery 1983;13:147.

52. Bell WO, Charney EB, Bruce DA, et al.. Symptomatic Arnold-Chiari malformation: Review of experience with 22 cases. J Neurosurg 1987;66(6):812—816.

53. Charney EB, Rorke LB, Sutton LN, et al.. Management of Chiari II complications in infants with myelomeningocele. J Pediatr 1987;111(3):364-371.

54. Gaston H. Ophthalmic complications of spina bifida and hydrocephalus. Eye 1991;5:279-290.

55. Lennerstrand G, Gallo JE, Samuelsson L. Neuro- ophthalmological findings in relation to CNS lesions in patients with myelomeningocele. Dev Med Child Neurol 1990; 32(5):423-431.

56. Pollack IF, Kinnunen D, Albright AL. The effect of early craniocervical decompression on functional outcome in neonates and young infants with myelodysplasia and symp­tomatic Chiari II malformations: results from a prospective series. Neurosurgery 1996;38(4):703-710.

57. McLone DG,NakaharaS, Knepper PA.ChiariII malformation: pathogenesis and dynamics. Concepts Pediatr Neurosurg 1991;11:1-17.

58. McLone DG, Dias MS. The Chiari II malformation: cause and impact. Childs Nerv Syst 2003 Aug;19(7-8):540-550.

59. Dirks PB, Drake JM, Lamberti-Pasculli M, et al. Falling ventriculo-peritoneal shunt rates in myelomeningocele. Childs Nerv Syst 2005;19:607.

60. Tulipan N, Sutton LN, Bruner JP, et al.. The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatr Neurosurg 2003;38(1):27-33.

61. Chatkupt S, Skurnick JH, Jaggi M, et al. Study of genetics, epidemiology and vitamin usage in familial spina bifida in the United States in the 1990s.

62. Lemire RJ. Neural tube defects. JAMA 1988;259(4): 558-562.

63. Gardner WJ: Myelocele. Rupture of the neural tube? Clin Neurosurg 1968;15:57-79.

64. Steinbok P, Irvine B, Cochrane DD, et al.. Long-term outcome and complications of children with myelomeningocele. Childs Nerv Syst 1992;8(2):92-96.

65. Mirzai H, Ersahin Y, Mutluer S, et al. Outcome of patients with meningomyelocele: The Ege University experience. Childs Nerv Syst 1998;14(3):120-123.

66. Wiswell TE, Tuttle DJ, Northam RS, et al. Major congenital neurologic malformations. A 17-year survey. Am J Dis Child 1990;144(1):61-67.

67. Cowchock S, Ainbender E, Prescott G, et al. The recurrence risk for neural tube defects in the United States: A collabo­rative study. Am JMed Genet 1980;5(3):309-314.

68. Morrison K, Papapetrou C, Attwood J, et al. Genetic map­ping of the human homologue (T) of mouse T (Brachyury) and a search for allele association between human T and spina bifida. Hum Mol Genet 1996;5(5):669 - 674.

69. Jones RF, Kwok BC, Stening WA, et al. The current status of endoscopic third ventricullostomy in the management of non-communicating hydrocephalus. Minim Invas Neurosurg 1994;37:28-36.

70. Teo C, Jones R. Management of hydrocephalus by endo­scopic third ventriculostomy in patients with myelomenin­gocele. Pediatr Neurosurg 1996;25(2):57-63.

71. Warf BC. Comparison of endoscopic third ventriculostomy alone and combined with choroids plexus cauterization in infants younger than 1 year of age: Aprospective study in 550 African children. JNeurosurg 2005;103(6 Suppl):475-481.

72. Kawamura T, Morioka T, Nishio S, et al. Cerebral abnormal­ities in lumbosacral neural tube closure defect: MR imaging evaluation. Childs Nerv Syst 2001;17(7):405-410.

73. Jones, KL. Smiths Recognizable Patterns of Human Malformations. 5th Ed. Philadelphia: WB Saunders, 2005.

74. Molnar GE, Alexander MA. Pediatric Rehabilitation. 3rd ed. Hanley and Belfus, Inc., 1999.

75. Bliton MJ, Zaner RM. Over the cutting edge: How ethics consultation illuminates the moral complexity of open- uterine fetal repair of spina bifida and patients' decision making. J Clin Ethics 2001;12(4):346-360.

76. Pringle KC. In utero surgery. Adv Surg 1986;19:101-138.

77. Lyerly AD, Mahowald MB. Maternal fetal surgery: The fal­lacy of abstraction and the problem of equipoise. Health Care Anal 2001;9(2):151-165.

78. Tulipan N, Hernanz-Schulman M, Bruner JP. Reduced hind­brain herniation after intrauterine myelomeningocele repair: A report of four cases. Pediatr Neurosurg Nov;29(5):274-278.

79. Brocklehurst G. Spina Bifida for the clinician. Clin Devel Med 1976;57.

80. Tuli S, Tuli J, Drake J, et al. Predictors of death in pediatric patients requiring cerebrospinal fluid shunts. J Neurosurg 2004;100(5 suppl):442-446.

81. Gonzales ET, Bauer SB, eds. Pediatric Urology Practice. Philadelphia: Lipponcott Williams and Wilkins, 1999.

82. Berger RM, Maizels M, Moran GC, et al. Bladder capacity (ounces) equals age (years) plus 2 predicts normal blad­der capacity and aids in diagnosis of abnormal voiding pat­terns. J Urol 1983;129(2):347-349.

83. Tarcan T, Bauer S, Olmedo E, et al. Long-term followup of newborns with myelo dysplasia and normaluro dynamic find­ings: Is followup necessary? J Urol 2001;165(2):564-567.

84. Soergel M, Cain M, Misseri R, et al. Transitional cell carci­noma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol 2004;172(4 Pt 2):1649-1651.

85. Franco I, Horowitz M, Grady R, et al. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia second­ary to neurogenic bladder dysfunction. J Urol 2005;173(1): 221-225.

86. Lapides J, Diokno AC, Silber SJ, et al. Clean, intermittent self-catheterization in the treatment of urinary tract dis­ease. J Urol 1972;107:458-461.

87. Phelan MW, Franks M, Somogyi GT, et al. Botulinum toxin urethral sphincter injection to restore bladder emp­tying in men and women with voiding dysfunction. J Urol 2001;165(4):1107-1110.

88. Harris CF, Cooper CS, Hutcheson JC, et al. Appendicovesicostomy: the Mitrofanoff procedure: A 15-year perspective. J Urol 2000;163(6):1922-1926.

89. Schlager TA, Clark M, Anderson S. Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent cathe­terization for bladder emptying. Pediatrics 2001;108(4):E71.

90. Kass EJ, Koff SA, Diokno AC, et al. The significance of bacilluria in children on long-term intermittent catheter­ization. J Urol 1981;126(2):223-225.

91. Ottolini MC, Shaer CM, Rushton HG, et al. Relationship of asymptomatic bacteriuria and renal scarring in children with neuropathic bladders who are practicing clean inter­mittent catheterization. J Pediatr 1995 Sep;127(3):368-372.

92. Van Hala S, Nelson VS, Hurvitz EA, et al. Bladder manage­ment in patients with pediatric onset neurogenic bladders. J Spinal Cord Med 1997;20(4):410-415.

93. Johnson HW, Anderson JD, Chambers GK, et al. A short­term study of nitrofurantoin prophylaxis in children man­aged with clean intermittent catheterization. Pediatrics 1994 May;93(5):752-755.

94. Schlager, TA, Dilks S, Trudell J, et al. Bacteriuria in children with neurogenic bladder treated with intermittent cathe­terization: natural history. J Pediatr 1995;126(3):490-496.

95. Jayawardena V, Midha M: Significance of bacteriuria in neurogenic bladder. J Spinal Cord Med 2004;27(2):102-105.

96. Kessler Tm, Lackner J, Kiss G, et al. Early proactive man­agement improves upper urinary tract function and reduces the need for surgery in patients with myelomenin­gocele. Neurourol Urodyn 2006;25(7):758-762.

97. Bruschini H, Almeida FG, Srougi M. Upper and lower uri­nary tract evaluation of 104 patients with myelomenin­gocele without adequate urological management. World J Urol 2006;24(2):224-228.

98. Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dys­function due to myelomeningocele: neonatal versus child­hood treatment. J Urol 1997;157(6) :2295-2297.

99. Joseph DB, Bauer SB, Colodny AH, et al. Clean intermit­tent catheterization in infants with neurogenic bladder. Pediatrics 1989;84(1):78-82.

100. Metcalfe PD, Cain MP, Kaefer M, et al. What is the need for additional bladder surgery after bladder augmentation in childhood? J Urol 2006; 176(4 Pt 2):1801-1805.

101. Johnston LB, Borzyskowski M. Bladder dysfunction and neurological disability at presentation in closed spina bifida. Arch Dis Child 1998;79(1):33-38.

102. Oakeshott P, Hunt GM, Whitaker RH, et al. Perineal sensa­tion: An important predictor of long-term outcome in open spina bifida. Arch Dis Child 2007;92(1):67-70.

103. Borzyskowski M, Cox A, Edwards M, et al. Neuropathic blad­der and intermittent catheterization: social and psychological impact on families. Dev Med Child Neurol 2004;46(3):160-167

104. Moore C, Kogan BA, Parekh A. Impact of urinary inconti­nence on self-concept in children with spina bifida. J Urol 2004;171(4):1659-1662.

105. Van Savage JG, Yohannes P: Laparoscopic antegrade con­tinence enema in situ appendix procedure for refractory constipation and overflow fecal incontinence in children with spina bifida. J Urol 2000;164(3 Pt 2):1084-1087.

106. Piggott H. The natural history of scoliosis in myelodyspla­sia. J Bone Joint Surg 1980;62(1):54-58.

107. Guille JT, Sarwark JF, Sherk HH, et al. Congenital and devel­opmental deformities of the spine in children with myelom­eningocele. J Am Acad Orthop Surg 2006;14(5):294-302.

108. Glard Y, Launay F, Viehweger E, et al. Neurological classi­fication in myelomeningocele as a spine deformity predic­tor. J Pediatr Orthop B 2007;16(4):287-292.

109. Ko AL, Song K, Ellenbogen RG, et al. Retrospective review of multilevel spinal fusion combined with spinal cord transection for treatment of kyphoscoliosis in pediatric myelomeningocele patients. Spine 2007;32(22):2493-2501.

110. Wild A, Haak H, Kumar M, et al. Is sacral instrumentation mandatory to address pelvic obliquity in neuromuscular thoracolumbar scoliosis due to myelomeningocele? Spine 2001;26(14):E325-329.

111. Wai EK, Young NL, Feldman BM, et al. The relationship between function, self-perception, and spinal deformity: Implications for treatment of scoliosis in children with spina bifida. J Pediatr Orthop 2005;25(1):64-69.

112. Maruyama T, Takeshita K. Surgical treatment of scolio­sis: a review of techniques currently applied. Scoliosis 2008;3:6.

113. Torre-Healy A, Samdani AF. Newer technologies for the treatment of scoliosis in the growing spine. Neurosurg Clin N Am 2007;18(4):697-705.

114. Broughton NS, Menelaus MB, Cole WG, Shurtleff DB. The natural history of hip deformity in myelomeningocele. J Bone Joint Surg 1993;75(5):760-763.

115. Heeg M, Broughton NS, Menelaus MB. Bilateral disloca­tion of the hip in spina bifida: A long-term follow-up study. J Pediatr Orthop 1998;18(4):434-436.

116. Snela S, Parsch K. Follow-up study after treatment of knee flexion contractures in spina bifida patients. J Pediatr Orthop B 2000;9(3):154-160.

117. Stevens PM, Klatt J. Guided growth for fixed knee flexion deformity. J Pediatr Orthop 2008;28(6):632-639.

118. Dias LS, Jasty MJ, Collins P. Rotational deformities of the lower limb in myelomeningocele. Evaluation and treat­ment. J Bone Joint Surg Am 1984;66(2):215-223.

119. Dosa NP, Eckrich M, Katz DA, et al. Incidence, preva­lence, and characteristics of fractures in children, adoles­cents, and adults with spina bifida. The J Spinal Cord Med 2007;30(Suppl 1):S5-9.

120. Mazur JM, Shurtleff D, Menelaus M, et al. Orthopaedic management of high-level spina bifida. Early walking compared with early use of a wheelchair. J Bone Joint Surg Am 1989;71(1):56-61.

121. Hassler J. The influence of ankle-foot orthoses on gait and energy expenditure in spina bifida. Pediatr Phys Ther 2001;13(3):146-147.

122. Swank M, Dias LS. Walking ability in spina bifida patients: a model for predicting future ambulatory status based on sitting balance and motor level. J Pediatr Orthop 1994;14(6):715-718.

123. Williams EN, Broughton NS, Menelaus MB. Age-related walking in children with spina bifida. Dev Med Child Neurol 1999;41(7):446-449.

124. Schoenmakers MA, Gulmans VA, Gooskens RH, et al. Spina bifida at the sacral level: More than minor gait dis­turbances. Clin Rehabil 2004;18(2):178-185.

125. Rendeli C, Nucera E, Ausili E, et al. Latex sensitisation and allergy in children with myelomeningocele. Childs Nerv Syst 2006;22(1):28-32.

126. Ausili E, Tabacco F, Focarelli B, et al. Prevalence of latex allergy in spina bifida: Genetic and environmental risk factors. Eur Rev Med Pharmacol Sci 2007;11(3):149-153.

127. Cremer R, Lorbacher M, Hering F, et al. Natural rubber latex sensitisation and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia com­pared with a normal paediatric population. Eur J Pediatr Surg 2007;17(3):194-198.

128. Eiwegger T, Dehlink E, Schwindt J, et al. Early exposure to latex products mediates latex sensitization in spina bifida but not in other disease with comparable latex exposure rates. Clin Exp Allergy 2006;36(10): 1242-1246.

129. Szepfalusi Z, Seidl R, Bernert G, et al. Latex sensitization in spina bifida appears disease-associated. J Pediatr 1999 Mar; 134(3):344-348.

130. Blanco C. Latex-Fruit Syndrome. Curr Allergy Asthma Rep 2003;3(1):47-53.

131. Rolland JM, O’Hehir RE. Latex allergy; a model for ther­apy. Clin Exp Allergy 2008;38(6):898-912.

132. Dosa NP, Foley JT, Eckrich M, et al. Obesity across the lifespan among persons with spina bifida. Disabil Rehabil 2008;26:1-7.

133. Roux G, Sawin KJ, Bellin MG, et al. The experience of adolescent women living with spina bifida. Part II: Peer relationships. Rehabil Nurs 2007;32(3):112-119.

134. Carel JC, Leger J. Clinical practice. Precocious puberty. N Engl J Med 2008;358(22):2366-2377.

135. Rotenstein D, Bass AN. Treatment to near adult stature of patients with myelomeningocele with recombinant human growth hormone. J Pediatr Endocrinol Metab 2004;17(9):1195-1200.

136. Valtonen KM, Goksor LA, Jonsson O, et al. Osteoporosis in adults with meningomyelocele: and unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil 2006;87(3):376-382.

137. Parfitt AM. The two faces of growth: Benefits and risks to bone integrity. Osteoporos Int 1994;4(6):382-398.

138. Bailey DA, McCulloch RA. Are there childhood ante­cedents for an adult health problem? Can J Pediatr 1992;5:130-134.

139. Quan A, Adams R, Ekmark E, et al. Bone mineral den­sity in children with myelomeningocele. Pediatrics 1998; 102(3):E34.

140. Kumar SJ, Cowell HR, Townsend P. Physeal, metaphyseal, and diaphyseal injuries of the lower extremities in children with myelomeningocele. J Pediatr Orthop 1984;4(1):25-27.

141. James CCM. Fractures of the lower limbs in spina bifida cystica: a survey of 44 fractures in 122 children. Dev Med Child Neurol 1970;12(suppl 22):88-93.

142. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002;110(1 Pt 1):e5.

143. Bianchi ML, Mazzanti A, Galbiati E, et al. Bone mineral density and bone metabolism in Duchenne muscular dys­trophy. Osteoporos Int 2003; 14(9):761 767.

144. Zehnder Y, Luthi M, Michel D, et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spi­nal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos Int 2004;15(3):180-189.

145. Henderson RC, Lin PP, Greene WB. Bone mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg 1995;77(11):1671-1681.

146. Harcke HT, Taylor A, Bachrach S, et al. Lateral femoral scan: an alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Radiol 1998;28(4):241-246.

147. Rosenstein BD, Greene WB, Herrington RT, et al. Bone density in myelomeningocele: the effects of ambula­tory status and other factors. Dev Med Child Neurol 1987;29(4):486-494.

148. Quan A, Adams R, Ekmark E, et al. Bone mineral density in children with myelomeningocele: effect of hydrochloro­thiazide. Pediatr Nephrol 2003;18(9):929-933.

149. Mingin GC, Nguyen HT, Mathias RS, et al. Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics 2002;110(6):1193-1198.

150. Apkon SD, Fenton L, Coll JR. Bone mineral density in children with myelomeningocele. Dev Med Child Neurol 2009;51(1):63-67.

151. Greer FR, Krebs NF. Committee on Nutrition: Optimizing Bone Health and Calcium Intakes of Infants, Children, and Adolescents. Pediatrics 2006;117(2):578-585.

152. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington DC: National Academy Press, 1997.

153. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122(5):1142-1152.

154. Chad KE, Bailey DA, McKay HA, et al. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 1999;135(1):115-117.

155. Caulton JM, Ward KA, Alsop CW, et al. A randomised con­trolled trial of standing programme on bone mineral den­sity in non-ambulant children with cerebral palsy. Arch Dis Child 2004;89(2):131-135.

156. Sholas MG, Tann B, Gaebler-Spira D. Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series. J Pediatr Orthop 2005;25(3):326-331.

157. Lowing K, Astrom E, Oscarsson KA, et al. Effect of intra­venous pamidronate therapy on everyday activities in children with osteogenesis imperfecta. Acta Paediatr 2007;96(8):1180-1183.

158. Bachrach SJ, Kecskemethy HH, Harcke HT, et al. Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy. J Clin Densitom 2006;9(2):167-174.

159. Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol 1971;13(3):279-303.

160. Snow JH, Prince M, Souheaver G, et al. Neuropsychological patterns of adolescents and young adults with spina bifida. Arch Clin Neuropsychol 1994;9(3):277-287.

161. Lindquist B, Persson EK, Uvebrant P, et al. Learning, memory and executive functions in children with hydro­cephalus. Acta Paediatr 2008;97(5):596-601.

162. Iddon JL, Morgan DJ, Loveday C, et al. Neuropsychological profile of young adults with spina bifida with or without hydrocephalus. J Neurol Neurosurg Psychiatry 2004;75(8): 1112-1118.

163. Boyer KM, Yeates KO, Enrile BG. Working memory and information processing speed in children with myelom­eningocele and shunted hydrocephalus: analysis of the children’s paced auditory serial addition test. J Int Neuropsychol Soc 2006;12(3):305-313.

164. Yeates KO, Enrile BG, Loss N, et al. Verbal learning and memory in children with myelomeningocele. J Pediatr Psychol 1995;20(6):801-815.

165. Fletcher JM, Copeland K, Frederick JA, et al. Spinal lesion level in spina bifida: A source of neural and cognitive het­erogeneity. JNeurosurg 2005;102(3 Suppl):268-279.

166. Hasan KM, Eluvathingal TJ, Kramer LA, et al. White mat­ter microstructural abnormalities in children with spina bifida myelomeningocele and hydrocephalus: a diffusion tensor tractography study of the association pathways. J Magn Reson Imaging 2008 Apr;27(4):700-9.

167. Matson MA, Mahone EM, Zabel TA. Serial neuropsycho­logical assessment and evidence of shunt malfunction in spina bifida: a longitudinal case study. Child Neuropsychol 2005;11(4):315-332.

168. Vinck A, Maassen B, Mullaart R, et al. Arnold-Chiari II malformation and cognitive functioning in spina bifida. J Neurol Neurosurg Psychiatry 2006;77(9):1083-1086.

169. Russell CL. Understanding nonverbal learning disorders in children with spina bifida. Teaching Exceptional Children 2004;36(4):8-13.

170. Vachha B, Adams RC. Memory and selective learning in children with spina bifida-myelomeningocele and shunted hydrocephalus: A preliminary study. Cerebrospinal Fluid Res 2005;2:10.

171. Rose BM, Holmbeck GN. Attention and executive func­tions in adolescents with spina bifida. J Pediatr Psychol 2007;32(8):983-994.

172. Burmeister R, Hannay HJ, Copeland K, et al. Attention problems and executive functions in children with spina bifida and hydrocephalus. Child Neuropsychol 2005;11(3):265-283.

173. Barnes M, Dennis M, Hetherington R. Reading and writ­ing skills in young adults with spina bifida and hydro­cephalus. J Int Neuropsychol Soc 2004;10(5):655-663.

174. Dise JE, Lohr ME. Examination of deficits in conceptual reasoning abilities associated with spina bifida. Am J Phys Med Rehabil 1998;77(3):247-251.

175. Binks JA, Barden WS, Burke TA, et al. What do we really know about the transition to adult-centered health care? A focus on cerebral palsy and spina bifida. Arch Phys Med Rehabil 2007;88(8):1064-1073.

176. Barf HA, Post MW, Verhoef M, et al. Life satisfaction of young adults with spina bifida. Dev Med Child Neurol 2007;49(6):458-463.

177. Verhoef M, Post MW, Barf HA, et al. Perceived health in young adults with spina bifida. Dev Med Child Neurol 2007;49(3):192-197.

178. Tomlinson P, Sugarman ID. Complications with shunts in adults with spina bifida. BMJ 1995;311(7000):286-287.

179. McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg 2000;10(Suppl 1):31-32.

180. Burnham R, Chan M, Hazlett C, et al. Acute median nerve dysfunction from wheelchair propulsion: The develop­ment of a model and study of the effect of hand protection. Arch Phys Med Rehabil 1994;75(5):513-518.

181. Singhal B, Mathew KM. Factors affecting mortality and morbidity in adult spina bifida. Eur J Pediatr Surg 1999;9 (Suppl 1):31-32.

182. Muller T, Arbeiter K, Aufricht C. Renal function in menin­gomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 2002;12(6):479-484.

183. Game X, Villers A, Malavaud B, et al. Bladder cancer aris­ing in a spina bifida patient. Urology 1999;54(5) :923.

184. Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol 2007;178(3 Pt 1):798-801.

185. Kinsman SL, Doehring MC. The cost of preventable con­ditions in adults with spina bifida. Eur J Pediatr Surg 1996;6(Suppl 1):17-20.

186. Arata M, Grover S, Dunne K, et al. Pregnancy outcome and complications in women with spina bifida. J Reprod Med 2000;45(9):743-748.

187. Wright LE, Alderson JD, Ash D, et al. Clinical risk: identi­fying latex allergy in adults with spina bifida. Eur J Pediatr Surg 2001;11 (Suppl 1):S47-48.

188. Obojski A, Chodorski J, Barg W, et al. Latex allergy and sen­sitization in children with spina bifida. Pediatr Neurosurg 2002;37(5):262-266.

189. Vroege JA, Zeijlemaker BY, Scheers MM. Sexual function­ing of adult patients born with meningomyelocele. A pilot study. Eur Urol 1998;34(1):25-29.

190. Lassmann J, Garibay Gonzalez F, Melchionni JB, et al. Sexual function in adult patients with spina bifida and its impact on quality of life. J Urol 2007;178(4 Pt 2):1611-1614

191. Hirayama A, Yamada K, Tanaka Y, et al. Evaluation of sex­ual function in adults with myelomeningocele. Hinyokika Kiyo 1995;41(12):985-989.

192. Decter RM, Furness PD 3rd, Nguyen TA, et al. Reproductive understanding, sexual functioning and testosterone levels in men with spina bifida. J Urol 1997;157(4):1466-1468.

193. Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol 2000;164(3 Pt 2):958-961.

194. van Mechelen MC, Verhoef M, van Asbeck FW, et al. Work participation among young adults with spina bifida in the Netherlands. Dev Med Child Neurol 2008; 50(10):772-777.